ID28470A - Formulasi-formulasi untuk perlindungan terhadap konjugasi polietilen glikol-interferon alfa - Google Patents
Formulasi-formulasi untuk perlindungan terhadap konjugasi polietilen glikol-interferon alfaInfo
- Publication number
- ID28470A ID28470A IDW20001920A ID20001920A ID28470A ID 28470 A ID28470 A ID 28470A ID W20001920 A IDW20001920 A ID W20001920A ID 20001920 A ID20001920 A ID 20001920A ID 28470 A ID28470 A ID 28470A
- Authority
- ID
- Indonesia
- Prior art keywords
- conjugation
- formulations
- glycol
- polyethylene
- protection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4890798A | 1998-03-26 | 1998-03-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID28470A true ID28470A (id) | 2001-05-24 |
Family
ID=21957085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20001920A ID28470A (id) | 1998-03-26 | 1999-03-24 | Formulasi-formulasi untuk perlindungan terhadap konjugasi polietilen glikol-interferon alfa |
Country Status (26)
Country | Link |
---|---|
EP (1) | EP1066059B1 (pt) |
JP (3) | JP3643034B2 (pt) |
KR (1) | KR100420642B1 (pt) |
CN (1) | CN1191863C (pt) |
AR (1) | AR014772A1 (pt) |
AT (1) | ATE297761T1 (pt) |
AU (1) | AU754002B2 (pt) |
BR (1) | BR9909087A (pt) |
CA (1) | CA2324467C (pt) |
CO (1) | CO5080738A1 (pt) |
CZ (1) | CZ302005B6 (pt) |
DE (1) | DE69925820T2 (pt) |
ES (1) | ES2241272T3 (pt) |
HK (1) | HK1029754A1 (pt) |
HU (1) | HU228877B1 (pt) |
ID (1) | ID28470A (pt) |
IL (2) | IL138221A0 (pt) |
MY (1) | MY119227A (pt) |
NO (1) | NO329916B1 (pt) |
NZ (1) | NZ506631A (pt) |
PE (1) | PE20000338A1 (pt) |
PL (1) | PL193286B1 (pt) |
PT (1) | PT1066059E (pt) |
SK (1) | SK285284B6 (pt) |
TW (2) | TWI250024B (pt) |
WO (1) | WO1999048535A1 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3643034B2 (ja) * | 1998-03-26 | 2005-04-27 | シェーリング コーポレイション | PEG−インターフェロンα結合体の保護のための処方物 |
DE60041291D1 (de) * | 1999-04-08 | 2009-02-12 | Schering Corp | Behandlung von Nierenzellen-Karzinom |
US6605273B2 (en) | 1999-04-08 | 2003-08-12 | Schering Corporation | Renal cell carcinoma treatment |
US6362162B1 (en) | 1999-04-08 | 2002-03-26 | Schering Corporation | CML Therapy |
US6923966B2 (en) | 1999-04-08 | 2005-08-02 | Schering Corporation | Melanoma therapy |
MXPA02007172A (es) * | 2000-01-24 | 2002-12-13 | Schering Corp | Combinacion de temozolomida y alfa interferon pegilado para tratamiento de cancer. |
EP1908477A3 (en) * | 2000-01-24 | 2008-06-11 | Schering Corporation | Combination of temozolomide and pegylated interferon-alpha for treating cancer |
KR100353392B1 (ko) * | 2000-03-13 | 2002-09-18 | 선바이오(주) | 높은 생체 활성도를 갖는 생체 활성 단백질과 peg의결합체 제조방법 |
WO2001074400A1 (fr) | 2000-04-03 | 2001-10-11 | Santen Pharmaceutical Co., Ltd. | Transporteurs et systeme de distribution de medicament les utilisant |
CN101172104B (zh) | 2002-02-22 | 2013-04-03 | 默沙东公司 | 抗肿瘤剂,特别是替莫唑胺的药物制剂,其制备方法和用途 |
AU2008201682B2 (en) * | 2004-02-02 | 2011-02-24 | Ambrx, Inc. | Modified human interferon polypeptides and their uses |
JP4971160B2 (ja) * | 2004-08-12 | 2012-07-11 | シェーリング コーポレイション | 安定するpeg化インターフェロン処方物 |
PT2234645E (pt) | 2007-12-20 | 2012-05-21 | Merck Serono Sa | Formulações de peg-interferão-beta |
KR101303388B1 (ko) * | 2010-10-26 | 2013-09-03 | 한미사이언스 주식회사 | 지속형 인터페론 알파 결합체의 액상 제제 |
JP2015535238A (ja) * | 2012-10-26 | 2015-12-10 | ルピン・リミテッドLupin Limited | ペグインターフェロンα−2bの安定な医薬組成物 |
KR101736870B1 (ko) | 2014-08-20 | 2017-05-18 | 한국코러스 주식회사 | 인터페론 접합체를 포함하는 복합체 및 이의 제조방법 |
EP4019007A1 (en) | 2016-06-01 | 2022-06-29 | Servier IP UK Limited | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
CN112358541B (zh) * | 2020-11-25 | 2022-04-01 | 广州迪澳医疗科技有限公司 | 一种重组人γ-干扰素的冻干保护剂 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2024046A1 (en) * | 1989-09-28 | 1991-03-29 | Alberto Ferro | Stabilized leukocyte-interferons |
US5382657A (en) * | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
WO1995013090A1 (en) * | 1993-11-10 | 1995-05-18 | Enzon, Inc. | Improved interferon polymer conjugates |
US5766582A (en) * | 1994-10-11 | 1998-06-16 | Schering Corporation | Stable, aqueous alfa interferon solution formulations |
US5738846A (en) * | 1994-11-10 | 1998-04-14 | Enzon, Inc. | Interferon polymer conjugates and process for preparing the same |
JP2000510813A (ja) * | 1995-02-06 | 2000-08-22 | ジェネテイックス・インスティテュート・インコーポレイテッド | Il−12用処方 |
TW426523B (en) * | 1995-04-06 | 2001-03-21 | Hoffmann La Roche | Interferon solution |
CN102416176A (zh) * | 1995-07-27 | 2012-04-18 | 基因技术股份有限公司 | 稳定等渗的冻干蛋白质制剂 |
CA2329474C (en) * | 1995-11-02 | 2002-02-26 | Schering Corporation | Continuous low-dose cytokine infusion therapy |
US5908621A (en) * | 1995-11-02 | 1999-06-01 | Schering Corporation | Polyethylene glycol modified interferon therapy |
TW517067B (en) * | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
JP3643034B2 (ja) * | 1998-03-26 | 2005-04-27 | シェーリング コーポレイション | PEG−インターフェロンα結合体の保護のための処方物 |
-
1999
- 1999-03-24 JP JP2000537581A patent/JP3643034B2/ja not_active Expired - Lifetime
- 1999-03-24 BR BR9909087-2A patent/BR9909087A/pt not_active Application Discontinuation
- 1999-03-24 CN CNB998044733A patent/CN1191863C/zh not_active Expired - Lifetime
- 1999-03-24 DE DE69925820T patent/DE69925820T2/de not_active Expired - Lifetime
- 1999-03-24 ES ES99913822T patent/ES2241272T3/es not_active Expired - Lifetime
- 1999-03-24 HU HU0101749A patent/HU228877B1/hu unknown
- 1999-03-24 PL PL345568A patent/PL193286B1/pl unknown
- 1999-03-24 CA CA002324467A patent/CA2324467C/en not_active Expired - Lifetime
- 1999-03-24 KR KR10-2000-7010588A patent/KR100420642B1/ko not_active IP Right Cessation
- 1999-03-24 AU AU31812/99A patent/AU754002B2/en not_active Expired
- 1999-03-24 AT AT99913822T patent/ATE297761T1/de active
- 1999-03-24 WO PCT/US1999/004268 patent/WO1999048535A1/en active IP Right Grant
- 1999-03-24 TW TW094125705A patent/TWI250024B/zh not_active IP Right Cessation
- 1999-03-24 ID IDW20001920A patent/ID28470A/id unknown
- 1999-03-24 CO CO99017875A patent/CO5080738A1/es unknown
- 1999-03-24 EP EP99913822A patent/EP1066059B1/en not_active Expired - Lifetime
- 1999-03-24 IL IL13822199A patent/IL138221A0/xx active IP Right Grant
- 1999-03-24 SK SK1426-2000A patent/SK285284B6/sk not_active IP Right Cessation
- 1999-03-24 CZ CZ20003315A patent/CZ302005B6/cs not_active IP Right Cessation
- 1999-03-24 NZ NZ506631A patent/NZ506631A/xx not_active IP Right Cessation
- 1999-03-24 TW TW088104662A patent/TWI243057B/zh not_active IP Right Cessation
- 1999-03-24 PT PT99913822T patent/PT1066059E/pt unknown
- 1999-03-25 MY MYPI99001145A patent/MY119227A/en unknown
- 1999-03-25 PE PE1999000243A patent/PE20000338A1/es not_active IP Right Cessation
- 1999-03-25 AR ARP990101323A patent/AR014772A1/es active IP Right Grant
-
2000
- 2000-09-03 IL IL138221A patent/IL138221A/en not_active IP Right Cessation
- 2000-09-25 NO NO20004785A patent/NO329916B1/no not_active IP Right Cessation
-
2001
- 2001-01-13 HK HK01100376A patent/HK1029754A1/xx not_active IP Right Cessation
-
2003
- 2003-02-07 JP JP2003031774A patent/JP2003221345A/ja active Pending
-
2004
- 2004-12-06 JP JP2004353441A patent/JP4580744B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22977A (id) | Konjugasi polietilen glikol-interferon alfa untuk terapi suatu infeksi | |
IS5555A (is) | Selekoxib lyfjablöndur | |
ID23546A (id) | Formulasi-formulasi ziprasidon | |
NO20005913D0 (no) | Legemiddelsammensetning | |
NO20004240L (no) | Formuleringer | |
ATE224703T1 (de) | Brauseformulierungen | |
NO992339D0 (no) | Farmas°ytiske formuleringer | |
ID28470A (id) | Formulasi-formulasi untuk perlindungan terhadap konjugasi polietilen glikol-interferon alfa | |
ID19979A (id) | Komposisi polietilena berisi | |
DE69900634D1 (de) | Shampoozusammensetzungen | |
PT1139739E (pt) | Formulacoes agroquimicas | |
PT1130966E (pt) | Formulacoes antiparasitarias | |
DE69804881D1 (de) | Knieschutzstruktur | |
DE69907454D1 (de) | Sonnenschutzformulierungen | |
MA24473A1 (fr) | Formulations | |
DE69812461D1 (de) | Gelenkschutz | |
DE69835287D1 (de) | Halogenierte harzzusammensetzungen | |
ATE357237T1 (de) | Formulierungen enthaltend cefuroxim-axetil | |
DE69926612D1 (de) | Modulare gelenkprothese | |
DE69913681T2 (de) | Schutzanordnung | |
ATA25298A (de) | Hufschutz | |
FR2789298B1 (fr) | Genouillere de protection de l'evidement rotulien | |
LV12255A (lv) | Antiseptikis koksnes kimiskai aizsardzibai | |
LV12179A (lv) | Antiseptikis koksnes kimiskai aizsardzibai | |
IT238116Y1 (it) | Pannolino ad elevata protezione igienica |